Sun Pharma announced strong third quarter results. Sales rose 15% to Rs 15,469 crore and net profit climbed 16% to Rs 3,368 crore. Growth was fueled by its branded businesses in India and emerging markets, along with global innovative medicines. The company also declared an interim dividend.
Sun Pharma Q3 profit jumps 16% YoY as branded and innovative businesses drive growth
📅 Published: January 31, 2026 |
📂 Category: Uncategorized